| Trial ID: | L5029 |
| Source ID: | NCT00370084
|
| Associated Drug: |
Itopride
|
| Title: |
Itopride Hydrochloride in Diabetes: Effects on Gastric Emptying and Glycemia
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Gastroparesis
|
| Interventions: |
DRUG: Itopride|OTHER: Placebo
|
| Outcome Measures: |
Primary: Gastric emptying assessment, weekly | Secondary: Glycemia, relief of upper gastrointestinal symptoms, intragastric meal distribution, weekly
|
| Sponsor/Collaborators: |
Sponsor: Forest Laboratories
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1|PHASE2
|
| Enrollment: |
25
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2005-03
|
| Completion Date: |
2006-07
|
| Results First Posted: |
|
| Last Update Posted: |
2017-02-09
|
| Locations: |
University of Adelaide, Department of Medicine, Adelaide, South Australia, 5000, Australia
|
| URL: |
https://clinicaltrials.gov/show/NCT00370084
|
